Valic Company Valuation
| VCBDX Fund | USD 9.75 0.02 0.21% |
At this time, the fund appears to be overvalued. Valic Company I has a current Real Value of $9.54 per share. The regular price of the fund is $9.75. We determine the value of Valic Company I from inspecting fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we recommend acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will draw towards each other.
Overvalued
Today
Please note that Valic Company's price fluctuation is very steady at this time. At this time, the fund appears to be overvalued. Valic Company I has a current Real Value of $9.54 per share. The regular price of the fund is $9.75. We determine the value of Valic Company I from inspecting fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we recommend acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will draw towards each other.
Since Valic Company is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Valic Mutual Fund. However, Valic Company's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.75 | Real 9.54 | Hype 9.75 | Naive 9.74 |
The intrinsic value of Valic Company's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Valic Company's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Valic Company I helps investors to forecast how Valic mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Valic Company more accurately as focusing exclusively on Valic Company's fundamentals will not take into account other important factors: About Valic Company Valuation
Our relative valuation model uses a comparative analysis of Valic Company. We calculate exposure to Valic Company's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Valic Company's related companies.The fund invests, under normal circumstances, at least 80 percent of net assets in medium- to high-quality fixed-income securities, including corporate debt securities of domestic and foreign companies, or in securities issued or guaranteed by the U.S. government such as treasury obligations, including treasury coupon strips and treasury principal strips, and other U.S. government securities, mortgage-related and mortgage-backed or non-mortgage asset-backed securities.
Other Information on Investing in Valic Mutual Fund
Valic Company financial ratios help investors to determine whether Valic Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valic with respect to the benefits of owning Valic Company security.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |